Beijing Tiantan Biological Products Co., Ltd.
SHH: 600161.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yanlin He
- Employees
- 5,298
- Headquarters
- Beijing, China
- IPO year
- 1998
- Market cap
- CN¥28.4B
- Website
- https://www.tiantanbio.com
Loading 600161…
Loading profile data…Frequently asked questions about 600161
What does Beijing Tiantan Biological Products Co., Ltd. (600161.SS) do?
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; hum...
Where does 600161.SS trade?
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) trades on the Shanghai Stock Exchange.
What sector is 600161.SS in?
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Beijing Tiantan Biological Products Co., Ltd.?
Yanlin He is the chief executive officer of Beijing Tiantan Biological Products Co., Ltd. (600161.SS).
Where is Beijing Tiantan Biological Products Co., Ltd. headquartered?
Beijing Tiantan Biological Products Co., Ltd. is headquartered in China.
Does 600161.SS pay a dividend?
Yes — Beijing Tiantan Biological Products Co., Ltd. (600161.SS) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600161.SS go public?
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) completed its initial public offering in 1998.